Barriers to hepatitis C treatment in the era of direct acting antiviral agents

BACKGROUND: Direct-acting antivirals (DAA) are safe, effective treatment of hepatitis C virus (HCV). Suboptimal linkage to specialists and access to DAAs are the leading barriers to treatment; however, data are limited. AIM: Determine predictors of follow-up, receipt of DAAs, and reasons for the lac...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Aliment Pharmacol Ther
मुख्य लेखकों: Lin, Michael, Kramer, Jennifer, White, Donna, Cao, Yumei, Tavakoli-Tabasi, Shahriar, Madu, Stella, Smith, Donna, Asch, Steven M., El-Serag, Hashem B., Kanwal, Fasiha
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5800315/
https://ncbi.nlm.nih.gov/pubmed/28949020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14328
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन